1. Home
  2. DOUG vs CNTN Comparison

DOUG vs CNTN Comparison

Compare DOUG & CNTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Douglas Elliman Inc.

DOUG

Douglas Elliman Inc.

HOLD

Current Price

$2.02

Market Cap

178.2M

Sector

Real Estate

ML Signal

HOLD

CNTN

Canton Strategic Holdings Inc. Common Stock

N/A

Current Price

$1.90

Market Cap

185.3M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
DOUG
CNTN
Founded
1911
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Building operators
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
178.2M
185.3M
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
DOUG
CNTN
Price
$2.02
$1.90
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
306.4K
732.3K
Earning Date
05-05-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
118.68
88.10
EPS
N/A
N/A
Revenue
$955,578,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.53
$1.75
52 Week High
$3.19
$5.27

Technical Indicators

Market Signals
Indicator
DOUG
CNTN
Relative Strength Index (RSI) 68.96 37.73
Support Level $1.70 $1.75
Resistance Level $2.05 $3.80
Average True Range (ATR) 0.08 0.14
MACD 0.02 0.02
Stochastic Oscillator 94.72 41.89

Price Performance

Historical Comparison
DOUG
CNTN

About DOUG Douglas Elliman Inc.

Douglas Elliman Inc is engaged in the real estate services business and seeks to acquire or invest in additional real estate services businesses. The Company also offers, through its subsidiaries and ventures, development marketing services and ancillary services, including mortgage, title, and escrow services. It generates revenue from commissions and other brokerage income, property management, and other ancillary services.

About CNTN Canton Strategic Holdings Inc. Common Stock

Canton Strategic Holdings Inc is engaged in activities related to Canton Network, including the use of Canton Coin, to support blockchain-based infrastructure and the digitization of financial market processes. The company also operates a validator node on the Canton Network to facilitate transaction validation and network operations. It also operates a clinical-stage biotech research and development arm. Its flagship clinical asset, GV104, is being developed for a specific indication for respiratory and/or nervous system depression in military personnel and chemical incident responders. The expanded pipeline includes other indications for GV104 and GV023, an approach to autoimmune diseases as well as an early-stage multispecific biologic platform.

Share on Social Networks: